SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-01
👔
Janux Therapeutics, Inc.
@JANX_InsiderForm 4 Filing: Campbell David Alan Gifts shares of $JANX
INSIDER GIFT
⚡ MATERIALITY: 2/10
corporate issuer
Janux Therapeutics, Inc.
Ticker: $JANX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-31
Shares: 123,840
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Campbell David Alan, holds the title of President and CEO at Janux Therapeutics, Inc..
On 2026-07-31, the insider transacted 123,840 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Campbell David Alan (President and CEO) gifted $0 of $JANX
Post-Transaction Position: 264,742 shares
SEC Accession No: 0001864158-26-000006 (CIK: 1864158)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.